Clinical Trial Update: Multiple Fields Radiotherapy Versus Intravenous Rituximab in the Treatment of Indolent Cutaneous Lymphomas B-cell With Multiple or Recurrent Lesions [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing multiple-field radiotherapy versus intravenous rituximab for indolent cutaneous B-cell lymphoma with multiple or recurrent lesi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Indolent Cutaneous B-cell Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: CHU de Reims | Conditions: Indolent Cutaneous B Cell Lymphomas | Phase 3 | Status: UNKNOWN